中文 | English
Return
Total: 20 , 1/2
Show Home Prev Next End page: GO
MeSH:(Clinical Trials, Phase III as Topic)

1.JCOG lung cancer surgery trial series: review and interpretation.

Run Ze LI ; Bin QIU

Chinese Journal of Oncology 2022;44(7):703-711

2.Comparison of paper and electronic data management in clinical trials.

Fang YIN ; Jun-chao CHEN ; Hong-xia LIU ; Ying-chun HE ; Qing-shan ZHENG

Acta Pharmaceutica Sinica 2015;50(11):1461-1463

3.Stereotactic radiosurgery: a "targeted" therapy for cancer.

Ming ZENG ; Liang-Fu HAN

Chinese Journal of Cancer 2012;31(10):471-475

4.Radioprotective effects on head and neck tumors of amifostine--a broad-spectrum cytoprotection.

Rui HUANG ; Haifang YU ; Anren KUANG

Journal of Biomedical Engineering 2002;19(4):708-711

6.Advance in thrombopoietic drugs used in treatment of children's immune thrombocytopenia.

Jing-Yao MA ; Run-Hui WU

Journal of Experimental Hematology 2012;20(6):1513-1517

7.Clinical research progression in chemoradiation therapy for resectable gastric cancer.

Ping WAN ; Min YAN ; Chao YAN ; Ren-da BI ; Chen LI

Chinese Journal of Gastrointestinal Surgery 2012;15(2):193-196

8.Effects of antiviral nucleotide/nucleoside analogues and interferon on hepatitis B virus-related liver cirrhosis: a meta-analysis.

Yi-si CHEN ; Wei YI ; Kun JIANG

Chinese Journal of Hepatology 2012;20(11):811-816

9.The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III.

Wen WU ; Cheng LU ; Si-yu CHEN ; Nie-fang YU

Acta Pharmaceutica Sinica 2009;44(3):242-257

10.Clinical Progress in the Immunotherapy of Small Cell Lung Cancer.

Weiwei WANG ; Jiaqi ZHANG ; Shanqing LI

Chinese Journal of Lung Cancer 2022;25(6):425-433

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 20 , 1/2 Show Home Prev Next End page: GO